Open AccessS704 Temporal Trends of Utilization of Biologics as First-Line Therapy in the Management of Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study
Author(s) -
Ahmed Eltelbany,
Abdul Hakim Mohammed,
Osama Hamid,
George Khoudari,
Miguel Regueiro
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776348.64683.9e
Subject(s) - medicine , ustekinumab , vedolizumab , infliximab , golimumab , certolizumab pegol , inflammatory bowel disease , adalimumab , natalizumab , ulcerative colitis , crohn's disease , population , colonoscopy , disease , cancer , colorectal cancer , environmental health